So what is this study about: Its scientific team has
isolated five cell populations from the placenta
with the potential to treat a variety of diseases,
based on their anti-inflammatory, angiogenic,
and immunomodulatory properties.
So despite reading: Active Companies in Tissue Engineering & Cell Therapy Stem cell and other pluripotentent cells, biomaterials and other products providing cell- and tissue-based regeneration and therapy
seeing
CorCell listed as one of the 150 along with
Pluristem Therapeutics Inc.,
Osiris Therapeutics Inc
Noting the study has been underway since Nov 2009... You don't believe there's any study? Hmmm, ok.